The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Open accessAbstract
Because melanogenesis can affect immune responses to and chemotherapy and radiotherapy for melanoma, we analyzed overall survival and disease-free survival times in melanoma patients in relation to the degree of tumor pigmentation. Clinicopathologic data were obtained from the Oncology Centre, Prof Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. The overall survival and disease-free survival analyses were performed using the log-rank test, whereas differences between mean/median overall survival and disease-free survival (days) were analyzed using the Student t test. In patients with metastatic disease, those with melanotic melanomas exhibited significantly shorter disease-free survival and overall survival than those with amelanotic lesions. Similarly, melanin-producing lymph node metastases were linked to shorter overall survival and disease-free survival, which was confirmed by a significantly longer mean/median disease-free survival for amelanotic versus melanotic metastases. Melanogenesis shortens overall survival and disease-free survival in patients with metastatic melanoma. Inhibition of melanogenesis appears a rational adjuvant approach to the therapy of metastatic melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of the VDR and CYP27B1 decreased during melanoma progression, and melanization and melanogenesis negatively affected both overall- and stage III disease-survival”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hauschild, A., Grob, J., Демидов, Л. В., Jouary, T., Gutzmer, R., Millward, M. J., Rutkowski, P. L., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 3,050
Melanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Self-citationMitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., Guerrero, C. R., Lennerz, J. K., Mihm, M. C., Wargo, J. A., et al. (2012) · Nature · doi:10.1038/nature11624 · Cited by 497
L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions
Slominski, A. T., Zmijewski, M. A., & Pawelek, J. M. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00898.x · Cited by 449
Self-citationSlominski, A. T., Zbytek, B., & Slominski, R. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24005 · Cited by 203
Self-citationMelanoma: New Insights and New Therapies
Nikolaou, V. A., Stratigos, A., Flaherty, K. T., & Tsao, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.421 · Cited by 164
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy
Brożyna, A. A., VanMiddlesworth, L., & Slominski, A. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23664 · Cited by 137
Self-citationExpression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
Self-citationSlominski, A. T., Paus, R., & Mihm, M. C. (1999) · PubMed · Cited by 109
Self-citationGidanian, S., Mentelle, M., Meyskens, F. L., & Farmer, P. J. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00309.x · Cited by 63
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–177 of 177
Ramtohul, T., Raïs, K. A., Gardrat, S., Barnhill, R. L., Roman‐Roman, S., Cassoux, N., Rodrigues, M. J., Mariani, P., de Koning, L., Pierron, G., et al. (2021) · Cancers · doi:10.3390/cancers13112728 · Cited by 14
Dong, C., Yang, S., Fan, R., Ji, K., Zhang, J., Liu, X., Hu, S., Jian-shan, X., Liu, Y., Gao, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12567-1 · Cited by 14
Carlson, J. A., Xavier‐Júnior, J. C. C., Tarasen, A. J., Sheehan, C. E., Otto, G. A., Miller, V. A., Stephens, P. J., Elvin, J. A., Vergilio, J., Suh, J. H., et al. (2016) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000000729 · Cited by 15
Self-citationNiu, Z., Wang, X., Xu, Y., Yan, L., Gong, X., Zeng, Q., Zhang, B., Xi, J., Pei, X., Yue, W., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852803 · Cited by 14
Current position of TNF-α in melanomagenesis
Nenu, I., Tudor, D. V., Filip, G. A., & Bâldea, I. (2015) · Tumor Biology · doi:10.1007/s13277-015-3639-0 · Cited by 16
COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour
Silveira, T. L., Pang, L. Y., Domenico, A. I. D., Veloso, É. S., Silva, I. L. D., Puerto, H. L. D., Ferreria, E., & Argyle, D. J. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.633170 · Cited by 13
A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
Pinho, J. O., Matias, M., Godinho‐Santos, A., Amaral, J. D., Mendes, E., Perry, M. D. J., Francisco, A. P., Rodrigues, C. M. P., & Gaspar, M. M. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123011 · Cited by 14
Markiewicz, A., Donizy, P., Nowak, M., Krzyziński, M., Elas, M., Plonka, P. M., Orłowska-Heitzman, J., Biecek, P., Hoang, M. P., & Romanowska‐Dixon, B. (2022) · Cancers · doi:10.3390/cancers14112753 · Cited by 13
Danciu, C., Berkó, S., Varju, G., Balázs, B., Kemény, L. V., Németh, I. B., Cioca, A., Petruş, A., Dehelean, C. A., Cîtu, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160715425 · Cited by 13
Zhang, G., Cheng, Y., Chen, G., Tang, Y., Ardekani, G. S., Rotte, A., Martinka, M., McElwee, K. J., Xu, X., Wang, Q., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4854 · Cited by 13
Sheen, Y., Liao, Y., Lin, M., Chiu, H., Jee, S., Liau, J., Chang, Y., & Chu, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147431 · Cited by 11
Clinical characteristics of malignant melanoma in central China and predictors of metastasis
Shi, K., Zhu, X., Liu, Z., Sun, N., Gu, L., Yang, W., Xu, C. W., Zhang, Z., Xie, B., Yang, S., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.11219 · Cited by 13
Rodriguez, Y. I., Campos, L. E., Castro, M. G., Bannoud, N., Blidner, A. G., Filippa, V., Croci, D. O., Rabinovich, G. A., & Alvarez, S. E. (2020) · Cells · doi:10.3390/cells9112469 · Cited by 12
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion
Chemla, Y., Itzhaki, O., Melamed, S., Weller, C., Sade, Y., Manich, P., Reshef, K., Xenidis, N., Maliah, A., Levy, G., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.020 · Cited by 11
Mîndrilă, I., Osman, A., Mîndrilă, B., Predoi, M. C., Mihăiescu, D. E., & Buteică, S. A. (2021) · Pharmaceuticals · doi:10.3390/ph14101007 · Cited by 11
Singh, N. K., Verma, A. K., & Gupta, J. K. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010301957240424110023 · Cited by 11
Nath, K., NELSON, D. S., Putt, M., Leeper, D. B., Garman, B., Nathanson, K. L., & Glickson, J. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157125 · Cited by 10
Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma
Kashyap, S., Singh, M. K., Jha, J., Singh, L., Pushker, N., Sen, S., Venkatesh, P., Meel, R., & Lomi, N. (2020) · Human Cell · doi:10.1007/s13577-020-00397-9 · Cited by 10
Zhou, B., Sha, S., Tao, J., Li, J., Shen, C., Zhu, J., Tan, L., Dong, L., & Huang, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-24879-y · Cited by 9
Xuan, S. H., Park, Y. M., & Park, S. N. (2018) · Photochemistry and Photobiology · doi:10.1111/php.13064 · Cited by 9
Is single versus combination therapy problematic in the treatment of cutaneous melanoma?
Krattinger, R., Ramelyte, E., Dornbierer, J., & Dummer, R. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1650641 · Cited by 9
drexml: A command line tool and Python package for drug repurposing
Esteban‐Medina, M., de la Oliva, V., Herráiz-Gil, S., Peña-Chilet, M., Dopazo, J., & Loucera, C. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.02.027 · Cited by 9
Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells
Huang, R., Wang, Y., Teng, H., Xu, M., He, K., Shen, Y., Guo, G., Feng, X., Li, T., Zhou, B., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02237-4 · Cited by 8
Giannopoulou, A. F., Velentzas, A. D., Anagnostopoulos, A. K., Agalou, A., Papandreou, N. C., Katarachia, S. A., Koumoundourou, D. G., Konstantakou, E. G., Pantazopoulou, V. I., Delis, A. D., et al. (2021) · Cancers · doi:10.3390/cancers13092024 · Cited by 8
Bakr, M. N., Takahashi, H., & Kikuchi, Y. (2022) · Biomedicines · doi:10.3390/biomedicines10071478 · Cited by 8
Konstantakou, E. G., Velentzas, A. D., Anagnostopoulos, A. K., Giannopoulou, A. F., Anastasiadou, E., Papassideri, I. S., Voutsinas, G. E., Tsangaris, G. T., & Stravopodis, D. J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.11.015 · Cited by 8
Zhang, J., Ye, Z., Townsend, D. M., & Tew, K. D. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.06.002 · Cited by 7
Targeting ocular malignancies using a novel light-activated virus-like drug conjugate
Ma, S., Veld, R. V. H. I. ‘., Pinos, E. D. L., OSSENDORP, F. A., & Jager, M. J. (2024) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2024.12.001 · Cited by 7
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications
Sobolev, V. V., Tchepourina, E., Soboleva, A. G., Denisova, E., Korsunskaya, I. M., & Mezentsev, A. (2025) · Cells · doi:10.3390/cells14070534 · Cited by 7
Du, Y., Lv, G., Jing, C., Liu, J., & Liu, J. (2020) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2020.0026 · Cited by 6
Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma
Zhang, X., Lin, Z., Li, M., Gai, Y., Zheng, H., Li, F., Ruan, W., Hu, F., Chen, J., & Lan, X. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06258-5 · Cited by 7
Kuźbicki, Ł., & Brożyna, A. A. (2019) · Journal of Cutaneous Pathology · doi:10.1111/cup.13606 · Cited by 8
Self-citationMoralev, A. D., Аркадьевна, З. М., & Markov, A. V. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00422 · Cited by 6
Chen, R., Niu, L., Wu, L., He, Y., Liu, G., & Hong, K. (2022) · Medicine · doi:10.1097/md.0000000000030280 · Cited by 7
The potential impact of melanosomal pH and metabolism on melanoma
You, J., Yusupova, M., & Zippin, J. H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887770 · Cited by 6
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features
Paolino, G., Pampena, R., Ciaccio, S. M. D., Carugno, A., Cantisani, C., Nicola, M. R. D., Losco, L., Bortone, G., Mercuri, S. R., Costanzo, A., et al. (2024) · Medicina · doi:10.3390/medicina60081239 · Cited by 7
Blockade of CCR5 in melanoma: An alternative immune checkpoint modulator
Brehm, J. E., & Bedogni, B. (2019) · Experimental Dermatology · doi:10.1111/exd.14065 · Cited by 6
Melanin concentration maps by label-free super-resolution photo-thermal imaging on melanoma biopsies
Bouzin, M., Marini, M. A., Chirico, G. G., Granucci, F., Mingozzi, F., Colombo, R., D’Alfonso, L., Sironi, L., & Collini, M. (2021) · Biomedical Optics Express · doi:10.1364/boe.445945 · Cited by 6
Matteucci, M., Pesce, A., Guarino, S., Cassini, D., Cirillo, B., D’Andrea, V., Boselli, C., Artico, M., Forte, F., Covarelli, P., et al. (2025) · Medicina · doi:10.3390/medicina61091722 · Cited by 5
Limm, K., Dettmer, K., Reinders, J., Oefner, P. J., & Bosserhoff, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160348 · Cited by 5
PET Imaging of Melanoma Using Melanin-Targeted Probe
Ma, X., & Cheng, Z. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1205-7_29 · Cited by 5
Hu, G., Jiang, Y., Ma, J.-Y., & Zhan, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-12676-6 · Cited by 5
Joompang, A., Anwised, P., Luangpraditkun, K., Jangpromma, N., Viyoch, J., Viennet, C., & Klaynongsruang, S. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0130 · Cited by 5
Natural and Synthetic Bioactives for Skin Health, Disease and Management
Chamcheu, J. C., Walker, A. L., & Noubissi, F. K. (2021) · Nutrients · doi:10.3390/nu13124383 · Cited by 4
Jha, J., Singh, M. K., Singh, L., Pushker, N., Meel, R., Lomi, N., Bakhshi, S., Nag, T. C., Chosdol, K., Sen, S., et al. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-323181 · Cited by 4
Yonekura, S. (2021) · Anticancer Research · doi:10.21873/anticanres.15509 · Cited by 4
Stimulation of Melanogenesis by Nordihydroguaiaretic Acid in Human Melanoma Cells
Takekoshi, S., Nagata, H., & Kitatani, K. (2014) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.14033 · Cited by 4
Nakamura, S., Kunikata, T., Matsumoto, Y., Hanaya, T., Harashima, A., Nishimoto, T., & Ushio, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186640 · Cited by 4
Unravelling the role of melanogenesis in melanoma: oncogenic crosstalk and therapeutic prospects
Bhat, A. M., Bhat, I. A., & Abdullah, S. T. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04400-x · Cited by 3
Lin, Z., & Yang, L. (2024) · Scientific Reports · doi:10.1038/s41598-023-50614-2 · Cited by 4
Melanoma cells suppress mast cell function via a melanin‐dependent mechanism
Melo, F. R., Nyman, L., Menander, I. Ö., Grujić, M., & Pejler, G. (2025) · FEBS Journal · doi:10.1111/febs.70189 · Cited by 3
Quantitative active super-resolution thermal imaging: The melanoma case study
Marini, M. A., Bouzin, M., Scodellaro, R., D’Alfonso, L., Sironi, L., Granucci, F., Mingozzi, F., Chirico, G. G., & Collini, M. (2022) · BioMolecular Concepts · doi:10.1515/bmc-2022-0015 · Cited by 3
Zhou, Y., Lü, W., & Lee, H. J. (2025) · Journal of Innovative Optical Health Sciences · doi:10.1142/s179354582544002x · Cited by 2
Beitner, A., Abu-Abeid, A., Dayan, D., Gat, A., Miodovnik, M., Levy, C., & Nizri, E. (2025) · Melanoma Research · doi:10.1097/cmr.0000000000001019 · Cited by 2
Biomarkers in Melanoma: where are we now?
Johnson, D. B., & Sullivan, R. J. (2014) · Melanoma Management · doi:10.2217/mmt.14.19 · Cited by 2
Pópulo, H., Batısta, R., Sampaio, C., Pardal, J., Lopes, J. M., & Soares, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180392 · Cited by 2
Editorial: Role of pigmentation in melanoma
Brożyna, A. A., Poliseno, L., & Slominski, A. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1084717 · Cited by 2
Self-citationLattmann, E., Jovic, A., Kim, J. J., Pham, T., Corona, C., Lian, Z., Saini, K., Ray, M., Lu, V., Tastanova, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601235 · Cited by 2
CKS1 expression in melanocytic nevi and melanoma
Brożyna, A. A., Aplin, A. E., Cohen, C., Carlson, G. W., Page, A. J., Murphy, M. J., Slominski, A. T., & Carlson, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.23648 · Cited by 1
Self-citationDermatological Applications of EPR: Skin-Deep or In-Depth?
Krzykawska-Serda, M., Michalczyk‐Wetula, D., & Plonka, P. M. (2018) · Springer eBooks · doi:10.1007/978-981-13-2230-3_8 · Cited by 1
IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma
Probst, M., Höeller, C., Ferenci, P., Stättermayer, A. F., Beinhardt, S., Pehamberger, H., Kittler, H., & Grabmeier‐Pfistershammer, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112613
de Assis, L. V. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2019.tde-07052019-151824
8. 歩行障害をきたしたアルコール性ニューロパチーの1症例 (第15回日本リハビリテーション医学会関東地方会)
西, 将., 猪飼, 哲., 上久保, 毅., 武原, 格., & 宮野, 佐. (2001) · リハビリテーション医学 : 日本リハビリテーション医学会誌
Sex Hormone Receptor Signals in Human Malignancies
Miyamoto, H. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-174-6
Melanoma cells suppress mast cell growth via a melanin-dependent mechanismPreprint
Melo, F. R., Nyman, L., Menander, I. Ö., Grujic, M., & Pejler, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636204
Liu, Y., Wang, Q., Li, Q., & Ren, P. (2025) · Oncology Letters · doi:10.3892/ol.2025.14996
., H., Mohapatra, D., Shreya, S., Biswal, S., Naik, G. G., Malang, S. D., Kathait, P., Patel, P. K., ., S., Senapati, P. C., et al. (2025) · Pharmaceutical Sciences · doi:10.34172/ps.025.42140
Andrei, R. D., Voinea, S. C., Bordea, C. I., Noditi, A., Peleaşa, T.-M., & Blidaru, A. (2025) · Medicina · doi:10.3390/medicina61091542
Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization
Sopel, J., Sarad, K., Kozińska, A., Mokrzynski, K. T., Szczygieł, D., Murzyn, A. A., Drzał, A., Slominski, A. T., Szczygieł, M., & Elas, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031147
Self-citationAssociations Between Pigmentation and the Clinicopathologic and Immune Landscape of Melanoma
Ghali, H., Al-Bzour, A. N., Boby, A., Aflatooni, S., DePalo, D. K., Dugan, M. M., Coughlin, E. C., Mhaskar, R. S., Tsai, K. Y., Zager, J. S., et al. (2026) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000003223
Ben-Shalom, N., Parikh, S., Abramovitz, L., Yefet, R., Manich, P., Tussia-Cohen, D., Moskowitz, O., Parikh, R., Melamed, S., Polonsky, K., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117300
DDERMMAL, a melanocytic long non-coding RNA, confers DNA damage tolerance to melanoma cells
Adnane, S., Verheyden, Y., Cuomo, A., Bonaldi, T., & Leucci, E. (2026) · iScience · doi:10.1016/j.isci.2026.116251
Seretny, A., Adamek, G., Stępniewski, J., Cieśla, M., Nowak, W. N., Krutyhołowa, R., Petrovic, M., Tejchman, A., Mazan, M. M., Waś, H., et al. (2026) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70105
PET Imaging of Melanoma Using a Melanin-Targeted Probe
Ma, X., & Cheng, Z. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5619-8_21
BindingDB Entry 50048135: 2-Hydroxypyridine-
BindingDB (2018) · UC San Diego · doi:10.7270/q24f1sqn
Metadata
- Authors
- Brożyna, A. A., Jóźwicki, W., Carlson, J. A., & Slominski, A. T.
- Affiliations
- Nicolaus Copernicus University (PL)
- Albany Medical College (US)
- University of Tennessee Health Science Center (US)
- Corresponding author
- Slominski, Andrzej T.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 44
- Issue
- 10
- Pages
- 2071-2074
- ISSN
- 0046-8177 (ISSN-L)
- PMC
- PMC3783651
- OpenAlex
- W2062933772
- Cited by
- 175
- References
- 13
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 13 · 2023: 8 · 2022: 21 · 2021: 11 · 2020: 9 · 2019: 17 · 2018: 14 · 2017: 16 · 2016: 14 · 2015: 17 · 2014: 14 · 2013: 1
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Pathology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056666)
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Keywords
- melanogenesis, melanoma, tumor pigmentation, melanin, metastatic melanoma, lymph node metastasis, overall survival, disease-free survival, amelanotic melanoma, adjuvant therapy, melanogenesis inhibition
- MeSH terms
- Humans, Lymph Nodes, Lymphatic Metastasis, Melanoma, Melanosis, Neoplasm Staging, Poland, Skin Neoplasms, Comorbidity, Survival Rate, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
